ロード中...
Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
Mesenchymal stem cells (MSC) have received particular attention due to their ability to inhibit inflammation caused by cytokine storm induced by COVID-19. In this way some patients have been treated successfully. The aim of this study was to evaluate the safety and describe the clinical changes afte...
保存先:
| 出版年: | Aging Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
JKL International LLC
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7990366/ https://ncbi.nlm.nih.gov/pubmed/33815870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14336/AD.2020.1218 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|